ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
BioMarin Expands Vosoritide Clinical Program
November 18, 2020BioMarin Pharmaceutical announced the Company is expanding its clinical program for vosoritide, an investigational analog of C-type Natriuretic Peptide (CNP), with two new Phase 2 studies. -
BioMarin Announces New England Journal of Medicine Publishes Vosoritide Phase 2 Study Showing Sustained Annualized Growth Up to 42 Months in Children with Achondroplasia
June 24, 2019BioMarin Announces New England Journal of Medicine Publishes Vosoritide Phase 2 Study Showing Sustained Annualized Growth Up to 42 Months in Children with Achondroplasia. -
New Experimental Drug, Vosoritide, Combats Leading Cause of Dwarfism
June 24, 2019New Experimental Drug, Vosoritide, Combats Leading Cause of Dwarfism.
Pharma Sources Insight January 2025
